Whether you are looking for simple, short-term support for a particular project or long-term collaborative research project, Cognitalis' team will work closely with you to provide an efficient, flexible and objective-driven solution that precisely meets your needs and budgets.
Ligand-based drug design - if you have ligands for your target we can construct models of the target binding-site and design new scaffolds to interact with those models.
Fragment-based drug design - if you have small, weak affinity compounds that bind to the target we can use them as starting points for drug design.
Focused libraries - if you have selected a specific target or class of targets, we will design scaffolds guided by your chemical synthesis expertise.
Cognitalis' technology offers the following advantages to drug developers:
lower cost - In silico design reduces wasted effort in synthesis and maximises the data obtained from experimental assays.
rapid - Rapidly perform Virtual High Throughput Screening on existing or virtual chemistry libraries.
relevant - Predictive models directly from Partner's data, focused to the particular chemistry series of interest.